fully
human
tcrs
Disco
ver
ing
fully
human
TCRs
dev
elop
ING
TCR-
based
therapy
revo
lution
izing
Welcome to
T-knife

T-knife Therapeutics is a T-cell receptor (TCR) company building a pipeline of innovative therapeutics for solid tumor patients and their families.  ​

We are leveraging our proprietary, transgenic mouse platform in order to discover fully-human TCRs, naturally selected in vivo for optimal affinity and specificity.​

We then develop novel, best-in-class TCR therapies that target tumor-specific antigens in multiple, difficult to treat solid tumor indications.

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close